• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

How the visual cortex changes from birth to old age

Bioengineer by Bioengineer
May 29, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A study of post-mortem brain tissue reveals the human primary visual cortex (V1) develops gradually throughout life. The research, published in The Journal of Neuroscience, may help to explain why the structure of this part of the brain matures in the first years after birth while vision continues to change throughout the lifespan.

Kathryn Murphy and colleagues obtained brain samples from 30 deceased individuals ranging from birth to 80 years of age to study how expression of a set of glutamatergic proteins (which regulate neurotransmission at a majority of synapses in human V1) changes in this region over time. The results show development of human V1 occurs in five different stages that mirror changes in vision. For example, the expression of three of these proteins peaks between 5 and 11 years of age, which coincides with the end of the period when children are susceptible to developing amblyopia, or lazy eye. Another protein did not peak until about 40 years of age and then dropped dramatically, by about 75 percent, in adults over 55 years of age, perhaps signaling degeneration in human V1.

The authors conclude that their work may inform the development of vision therapies for individuals of different ages.

###

About JNeurosci

The Journal of Neuroscience (JNeurosci) is the flagship journal of the Society for Neuroscience. JNeurosci publishes papers on a broad range of topics in neuroscience in a print edition each Wednesday and recently began publishing early-release PDFs of studies online shortly after acceptance.

The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 38,000 members in more than 90 countries and over 130 chapters worldwide.

Article: Development of glutamatergic proteins in human visual cortex across the lifespan

DOI: https://doi.org/10.1523/JNEUROSCI.2304-16.2017

Corresponding author: Kathryn Murphy (McMaster University, Hamilton, Ontario, Canada), [email protected]

Press contact: Wade Hemsworth, [email protected]

Media Contact

David Barnstone
[email protected]
202-962-4000
@sfntweets

http://www.sfn.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Brain Metastases Show Unique Macrophage Spatial Patterns

April 1, 2026

PRSS56 Drives and Treats Human High Myopia

April 1, 2026

Wastewater Study Maps US Antibiotic Resistance Patterns

April 1, 2026

Linking Health Quality and Life Meaning in Elders

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

KIST-IAE Collaborative Team Surpasses Performance Limits in Lithium-Air Batteries with Innovative Two-Dimensional Catalyst

Brain Metastases Show Unique Macrophage Spatial Patterns

PRSS56 Drives and Treats Human High Myopia

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.